Urinalysis Market is expected to grow with an impressive CAGR in the forecast period of 2024-2028. This can be attributed to factors such as growing chronic disease prevalence such as diabetes, kidney disease, etc.
Urinalysis is a test that examines the visual, chemical, and microscopic characteristics of urine.
Moreover, rising awareness for kidney and urinary tract infections among the population and increasing government initiatives along with growing healthcare investments for the identification and management of growing burden of kidney diseases, are some factors adding to the market growth and is anticipated to bolster the Global Urinalysis Market in the forecast period.
Rising Prevalence of Chronic Disease
according to the National Diabetes Statistical Report, in 2020, approximately 34.2 million people aged 18 yrs. and above were affected with diabetes. Also, around one-third of the population were suffering some kind of kidney complication due to the constant elevated blood pressure and blood sugar.
Growing Burden of Urinary Tract Infections (UTIs)
Urinalysis is a commonly utilized diagnostic procedure in identification of a Urinary Tract infections (UTI). The diagnostic procedure examines the urine by detecting and identifying cells, bacteria, virus, protein, creatinine, and substances present in abnormal concentration.
Popularity of at-home Urine Testing Kits
At-home urine test kits are found at for testing the presence of urinary tract infection at homes. The UTI test kits commonly work as pregnancy test kits, which indicate the presence of a urinary infection in few minutes at home. Also, these test kits are highly beneficial for testing the reoccurrence of a urinary tract infection, thereby taking further measures to get it cured. Furthermore, these test kits provide at home screening for urine drug test with 100% privacy. Kits are designed to diagnose marijuana, cocaine, methamphetamines, etc. This urine drug test kit is found at for home-based test suitable for home drug testing, workplace testing, school college university drug testing, law enforcement testing, substantial drug abuse testing, etc.
Recent Development
In November 2021, Vivoo- a wellness and nutrition guidance startup, raised $6 million in investment for the creation of at-home urine testing that offer dietary and lifestyle advice. Middle-low-income countries are investing in these inexpensive but similarly functional analyzers.
Market Segmentation
Global Urinalysis Market is segmented based on the product, test type, application, end user, and region. Based on the product, the market is segmented into consumables and instruments. Based on the test type, the market is segmented into pregnancy & fertility tests, biochemical urinalysis, and sediment urinalysis. Based on application, the market is fragmented into disease screening and pregnancy & fertility. Depending on the end user, the market is segmented into diagnostic laboratories, hospitals & clinics, home care settings, and research laboratories & institutes. Based on the region, the Market is further segmented into North America, Europe, Asia-Pacific, South America, and MEA.
Market Players
F. Hoffmann-La Roche Ltd., Siemens Healthineers AG., Abbott Laboratories, Cardinal Health Inc., Danaher Corporation, Sysmex Corporation, Quidel Coorporation, Becton, Dickinson & Company, Bio-Rad Laboratories Inc., EKF Diagnostic
Attribute | Details |
Base Year | 2022 |
Historical Years | 2018 – 2021 |
Estimated Year | 2023 |
Forecast Period | 2024 – 2028 |
Quantitative Units | Revenue in USD Million and CAGR for 2018-2022 and 2023-2028 |
Report Coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered | Product Test Type Application End User |
Regional Scope | North America; Asia Pacific; Europe; South America; Middle East & Africa |
Country Scope | United States; Canada; Mexico; China; India; Japan; South Korea; Australia; Germany; France; United Kingdom; Spain; Italy; Brazil; Argentina; Colombia; Saudi Arabia; UAE; South Africa; Kuwait |
Key Companies Profiled | F. Hoffmann-La Roche Ltd., Siemens Healthineers AG., Abbott Laboratories, Cardinal Health Inc., Danaher Corporation, Sysmex Corporation, Quidel Corporation, Becton, Dickinson & Company, Bio-Rad Laboratories Inc., EKF Diagnostic s Holdings plc |
Customization Scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and Purchase Options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |